Lisa C Goldfeder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lisa C Goldfeder has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Clifton Earl Barry
Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA
1 shared publication - Hongjo Choi
Division of Health Policy and Management, Korea University College of Health Science, Seoul, Republic of Korea
1 shared publication - Jong Seok Lee
Microbiology Research Section, International Tuberculosis Research Center, Changwon-si, 51755, Republic of Korea
1 shared publication - Joon-Sung Joh
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Center, Seoul, Korea
1 shared publication - Laura E. Via
Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
1 shared publication - Lori E. Dodd
National Institute of Allergy and Infectious Disease, Division of Clinical Research, Clinical Trials Research Section, Bethesda, Maryland, United States
1 shared publication
Latest Publications
- Open Access
- 2 July 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 360
Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012
Tuberculosis remains an important health concern in many countries. The aim of this study was to identify predictors of unfavorable outcomes at the end of treatment (EOT) and at the end of study (EOS; 40 months after EOT) in South Korea.
- 2 July 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 360
Open AccessPredictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012
Tuberculosis remains an important health concern in many countries. The aim of this study was to identify predictors of unfavorable outcomes at the end of treatment (EOT) and at the end of study (EOS; 40 months after EOT) in South Korea.